AU3860793A - Self-sticking matrix system for the sustained transcutaneous release of piribedil - Google Patents

Self-sticking matrix system for the sustained transcutaneous release of piribedil

Info

Publication number
AU3860793A
AU3860793A AU38607/93A AU3860793A AU3860793A AU 3860793 A AU3860793 A AU 3860793A AU 38607/93 A AU38607/93 A AU 38607/93A AU 3860793 A AU3860793 A AU 3860793A AU 3860793 A AU3860793 A AU 3860793A
Authority
AU
Australia
Prior art keywords
piribedil
self
sustained
matrix system
transcutaneous
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
AU38607/93A
Other versions
AU656266B2 (en
Inventor
Francoise Arnaud
Olivier Crambes
Alain Cuine
Gerald Pichon
Isabelle Rault
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Laboratoires Servier SAS
Original Assignee
Laboratoires Servier SAS
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Laboratoires Servier SAS filed Critical Laboratoires Servier SAS
Publication of AU3860793A publication Critical patent/AU3860793A/en
Application granted granted Critical
Publication of AU656266B2 publication Critical patent/AU656266B2/en
Assigned to LES LABORATOIRES SERVIER reassignment LES LABORATOIRES SERVIER Alteration of Name(s) in Register under S187 Assignors: ADIR ET COMPAGNIE
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
    • A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
    • A61K9/7053—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained by reactions only involving carbon to carbon unsaturated bonds, e.g. polyvinyl, polyisobutylene, polystyrene
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
    • A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
    • A61K9/7053—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained by reactions only involving carbon to carbon unsaturated bonds, e.g. polyvinyl, polyisobutylene, polystyrene
    • A61K9/7061—Polyacrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
    • A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
    • A61K9/7069—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained otherwise than by reactions only involving carbon to carbon unsaturated bonds, e.g. polysiloxane, polyesters, polyurethane, polyethylene oxide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Dermatology (AREA)
  • Neurology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Psychiatry (AREA)
  • Cardiology (AREA)
  • Hospice & Palliative Care (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Addiction (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Absorbent Articles And Supports Therefor (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Materials For Medical Uses (AREA)

Abstract

Matrix system made up of ethylene/vinyl acetate copolymer, self-adhesive for the extended release of piribedil. This system ensures the continuous and uniform diffusion of piribedil by a transcutaneous route.
AU38607/93A 1992-05-19 1993-05-18 Self-sticking matrix system for the sustained transcutaneous release of piribedil Ceased AU656266B2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR9206037A FR2691361B1 (en) 1992-05-19 1992-05-19 SELF-ADHESIVE MATRIX SYSTEM FOR THE EXTENDED RELEASE OF THE PIRIBEDIL BY TRANSCUTANEOUS ROUTE.
FR9206037 1992-05-19

Publications (2)

Publication Number Publication Date
AU3860793A true AU3860793A (en) 1993-11-25
AU656266B2 AU656266B2 (en) 1995-01-27

Family

ID=9429912

Family Applications (1)

Application Number Title Priority Date Filing Date
AU38607/93A Ceased AU656266B2 (en) 1992-05-19 1993-05-18 Self-sticking matrix system for the sustained transcutaneous release of piribedil

Country Status (11)

Country Link
EP (1) EP0571264B1 (en)
JP (1) JPH0632738A (en)
AT (1) ATE173623T1 (en)
AU (1) AU656266B2 (en)
CA (1) CA2096511A1 (en)
DE (1) DE69322201T2 (en)
DK (1) DK0571264T3 (en)
ES (1) ES2127259T3 (en)
FR (1) FR2691361B1 (en)
NZ (1) NZ247648A (en)
ZA (1) ZA933508B (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2675383B1 (en) * 1991-04-18 1995-05-12 Bernard Aranda USE OF A MEDICINAL PRODUCT FOR THE MANUFACTURE OF A MEDICINAL PRODUCT FOR THE TREATMENT OF HYPERACTIVE OR UNSTABLE BLADDER.
US5840327A (en) * 1995-08-21 1998-11-24 Alza Corporation Transdermal drug delivery device having enhanced adhesion
FR2744130B1 (en) * 1996-01-31 1998-03-20 Atohaas Holding Cv ADHESIVE COMPOSITION FOR (CO) POLYMER (METH) ACRYLIC MATERIALS
CN103373991A (en) * 2013-07-12 2013-10-30 安徽安腾药业有限责任公司 Method for preparing piribedil in high-purity high-yield manner

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2355502A1 (en) * 1976-06-23 1978-01-20 Roussel Uclaf APPLICATION AS A MEDICINAL PRODUCT OF A DERIVATIVE OF PIPERAZINE AND ITS SALTS
ATE109357T1 (en) * 1988-02-26 1994-08-15 Riker Laboratories Inc TRANSDERMAL ESTRADIOL AS A THERAPEUTIC SYSTEM.
FR2664815B1 (en) * 1990-07-23 1994-11-04 Adir SELF-ADHESIVE MATRIX SYSTEM FOR THE EXTENDED RELEASE OF THE PIRIBEDIL BY TRANSCUTANEOUS ROUTE.
GB9102089D0 (en) * 1991-01-31 1991-03-13 Johnson & Johnson Medical Net wound dressings

Also Published As

Publication number Publication date
ZA933508B (en) 1993-12-10
AU656266B2 (en) 1995-01-27
JPH0632738A (en) 1994-02-08
ATE173623T1 (en) 1998-12-15
ES2127259T3 (en) 1999-04-16
FR2691361B1 (en) 1994-07-08
DK0571264T3 (en) 1999-08-09
EP0571264B1 (en) 1998-11-25
NZ247648A (en) 1995-01-27
EP0571264A1 (en) 1993-11-24
CA2096511A1 (en) 1993-11-20
DE69322201T2 (en) 1999-06-24
DE69322201D1 (en) 1999-01-07
FR2691361A1 (en) 1993-11-26

Similar Documents

Publication Publication Date Title
AU6569694A (en) Active substance-containing plaster
AU650142B2 (en) Carrier catalyst, process for its preparation, and its use for the preparation of vinyl acetate
AU6383996A (en) Multiple-channel, total-reflection optic with controllable d ivergence
AU4875796A (en) Sheet-like, superabsorbent structures
EP0600470A3 (en) Bipolar membrane.
AU9003691A (en) Catalyst carrier
EP0643976A3 (en) Cardioplegia delivery system.
AU4501393A (en) Curving device, especially for seat backs
AU4681293A (en) Portable, integrated, universally adjustable position control system
AU2051188A (en) Controlling and supervising system for loom, etc.
EP0781788A3 (en) Unsaturated copolymer based on olefin and production and use thereof
TW349185B (en) A semiconductor device
AU2530092A (en) Cushion rivetless retainer ring
MY109271A (en) Ozone-friendly correction fluid containing a butyl methacrylate copolymer as a film forming binder
AU1746497A (en) Selective call transceiver with customized canned messages
AU656266B2 (en) Self-sticking matrix system for the sustained transcutaneous release of piribedil
AU8121391A (en) Self-sticking matrix system for the sustained transcutaneous release of piribedil
AU1037392A (en) Work station device for automatic assembly, assembly line and circular-type work station device for automatic assembly
IL98544A0 (en) Oxido reductase enzyme system obtainable from p.chrysogenum,its preparation and its use
AU7427194A (en) Control mechanism for the seat carriers of chairs, especially swivel chairs
AU3121597A (en) Nutritional support system
ES2154392T3 (en) THERMOFUSIBLE ADHESIVE COMPOSITIONS BASED ON COPOLYMERS THAT INCLUDE ETHYLENE, VINYL ACETATE AND VINYLALCOXISILANE.
EP0659077A4 (en) Controlled release pilocarpine delivery system.
AU4820990A (en) Substituted 3-azabicyclo(3.1.1)heptanes, their production and use
McLees The ruin speaks.... The church of the Benedictine Abbey of Nidarholm. Report from excavations on the island of Munkholmen, Trondheim 1988-1989

Legal Events

Date Code Title Description
PC Assignment registered

Owner name: LES LABORATOIRES SERVIER

Free format text: FORMER OWNER WAS: ADIR ET COMPAGNIE